🎉 Finosauras is now  SarasRead more
Glenmark Pharmaceuticals Ltd logo

Glenmark Pharmaceuticals Ltd - Share Price Target 2026

(NSE: GLENMARK)

Sector: Healthcare

Market Cap: 58649.79 Cr

1570.00

-

2400.00

Target Price Range

1989.80

-10.90 (-0.55%)

CMP

Bullish

As on 19 Jan 2026, 03:30 pm

Market Trends

Based on 6 research reports and 6 technical indicators.
Bullish8
Bearish2
Neutral2
Agg. Profit Potential13.68%
Agg. Risk 8.47%

Last updated on: 19/01/2026, 3:30 pm

Returns

PeriodReturn %
1 Month7.84
3 Months-2.79
1 Year28.80
5 Years280.74

Last updated on: 04/12/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
HDFC MUTUAL FUND - HDFC MID-CAP FUND6.2%17,502,243
GOVERNMENT PENSION FUND GLOBAL3.52%9,921,208
AMANSA HOLDINGS PRIVATE LIMITED2.07%5,846,321
INVESCO INDIA FLEXI CAP FUND2.04%5,753,006
SMALLCAP WORLD FUND, INC2.01%5,658,405
MIRAE ASSET NIFTY MIDCAP 150 ETF1.33%3,752,325

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

384.34

P/B Ratio

2.45

PEG Ratio

-0.39

ROE

6.78%

EPS

5.41

Dividend Yield

0.12%

Market Cap

58649.79 Cr

Sector

N/A

Last Updated: 8 Jan 2026, 02:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Glenmark Pharmaceuticals Ltd.

Incorporated Year

1977

City and State

Mumbai, Maharashtra

Listing Date

Director's Name

VS Mani

Revenue

10489.80 Cr

Net Profit

1610.35 Cr